XML 58 R17.htm IDEA: XBRL DOCUMENT v3.20.1

Legal Settlements and Loss Contingencies	3 Months Ended
	Mar. 31, 2020
Legal Settlements and Loss Contingencies	NOTE 9 – Legal settlements and loss contingencies: In the first quarter of 2020, Teva recorded an income of $25 million in legal settlements and loss contingencies, compared to an expense of $57 million in the first quarter of 2019. The income in the first quarter of 2020 was mainly due to a settlement of an action brought against the sellers of Auden McKenzie (an acquisition made by Actavis Generics).  As of March 31, 2020 and December 31, 2019, Teva’s provision for legal settlements and loss contingencies recorded under accrued expenses was $1,539 million and $1,580 million, respectively.

X

- Definition

The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-URI http://asc.fasb.org/topic&trid=2127136

+ Details

Name:	us-gaap_LegalMattersAndContingenciesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration